Literature DB >> 4148460

Editorial: New vasodilator drugs for hypertension.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4148460      PMCID: PMC1587294          DOI: 10.1136/bmj.4.5886.185

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients.

Authors:  I H PAGE; A C CORCORAN; H P DUSTAN; T KOPPANYI
Journal:  Circulation       Date:  1955-02       Impact factor: 29.690

2.  Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol.

Authors:  D W Clark; L I Goldberg
Journal:  Ann Intern Med       Date:  1972-04       Impact factor: 25.391

3.  Hemodynamic and therapeutic effects of guancydine in hypertension.

Authors:  J Hammer; M Ulrych; E D Freis
Journal:  Clin Pharmacol Ther       Date:  1971 Jan-Feb       Impact factor: 6.875

4.  Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

Authors:  E Gilmore; J Weil; C Chidsey
Journal:  N Engl J Med       Date:  1970-03-05       Impact factor: 91.245

5.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

6.  Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

Authors:  T B Gottlieb; F H Katz; C A Chidsey
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

7.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

8.  Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.

Authors:  H S Seltzer; J R Crout
Journal:  Ann N Y Acad Sci       Date:  1968-04-11       Impact factor: 5.691

9.  Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; K G Wakim; J W Worthington; L E Ward
Journal:  Medicine (Baltimore)       Date:  1967-01       Impact factor: 1.889

10.  Use of diazoxide in hypertension with renal failure.

Authors:  J E Pohl; H Thurston
Journal:  Br Med J       Date:  1971-10-16
View more
  1 in total

1.  Initial clinical experience with a new peripheral vasodilator, PR-G-138-Cl, in hypertensive patients.

Authors:  H P Blumental; J R Ryan; F G McMahon
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.